Over recent years, A&M has seen incredible growth in France. As the year ends, we look back at the success of 2021 and development the firm has seen within the French team.
The Paris-based team has grown from just over 30 people in 2018 to now over 130, demonstrating a growth of over 300% in three years. In 2021 alone, A&M France welcomed four new Managing Directors and introduced two new sector offerings to expand the breadth and depth of what the team can offer French clients and businesses.
2022 is off to a great start with the launch of A&M Digital EMEA, led by Jean-Laurent Poitou. Based in Paris, he will lead the development of a fully integrated digital offering in EMEA to deliver tangible business results for our clients. His joining marks the next phase of growth for A&M within France as the team continues to grow to meet client demand.
To read the full report, click here.
.
Navigating Q3 2025: Essential Income Tax Accounting Insights
October 10, 2025
Get Q3 2025 updates on ASC 740, IAS 12, OECD Pillar Two, and US tax rules like ASU 2023-09 reshaping global tax accounting and financial reporting practices.
German TP update: amended Guidance on International Mutual Agreement and Arbitration Procedures
October 10, 2025
Germany streamlines cross-border tax dispute resolution with new electronic procedures and clarified arbitration rules — marking a major step toward greater efficiency and international tax alignment.
Episode 12: ‘I put everything on the line for MBO’
October 9, 2025
Join Jonathan Boyers, Head of Alvarez & Marsal Corporate Finance, and Chris Maguire, Executive Editor of BusinessCloud, as they sit down to interview Matt Hirst, CEO of ESG.
Navigating Global Pharma Policy
October 9, 2025
As the U.S. considers imposing tariffs on European pharmaceutical imports, the ripple effects could be felt across the global healthcare landscape. For an industry already grappling with rising R&D costs and competitive pressures, these tariffs threaten to erode profit margins and disrupt finely tuned supply chains.